Skip to main content

. 1975 Aug 9;3(5979):339. doi: 10.1136/bmj.3.5979.339

Editorial: Neuropharmacological aspects of migraine.

PMCID: PMC1673784 PMID: 1156746

339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
KIMBALL R. W., FRIEDMAN A. P., VALLEJO E. Effect of serotonin in migraine patients. Neurology. 1960 Feb;10:107–111. doi: 10.1212/wnl.10.2.107. [DOI] [PubMed] [Google Scholar]
Sjaastad O. The significance of blood serotonin levels in migraine. A critical review. Acta Neurol Scand. 1975 Mar;51(3):200–210. doi: 10.1111/j.1600-0404.1975.tb07601.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES